Novavax Inc

Затворен

СекторЗдравеопазване

9.43 6.43

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

8.26

Максимум

8.97

Ключови измерители

By Trading Economics

Приходи

-44M

-53M

Продажби

-83M

57M

P/E

Средно за сектора

3.112

57.371

EPS

-0.32

Марж на печалбата

-94.16

Служители

749

EBITDA

-39M

-40M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+48.21% upside

Дивиденти

By Acuity

Следващи печалби

5.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

113M

1.3B

Предишно отваряне

3

Предишно затваряне

9.43

Настроения в новините

By Acuity

13%

87%

17 / 340 Класиране в Healthcare

Novavax Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.08.2026 г., 20:04 ч. UTC

Novavax shares are lower today, reflecting broader market trends, with no specific company news identified. The stock remains above its 20-day moving average.

21.08.2026 г., 23:31 ч. UTC

Novavax Inc. shares declined in after-market trading, moving within a narrow range since Friday's close. The stock remains above its 20-day moving average.

20.08.2026 г., 19:02 ч. UTC

Macro Event

Novavax shares are trading lower amid negative jobless claims data, reflecting broader market fluctuations and a significant decline since Wednesday's close.

19.08.2026 г., 23:51 ч. UTC

Novavax Inc. shares are lower in after-market hours amid broader declines in biotechnology stocks, despite an earlier session peak above Wednesday's close.

17.08.2026 г., 19:36 ч. UTC

Novavax Inc is trading higher, reaching a session peak earlier today. The stock remains at the upper end of its one-month trading range.

14.08.2026 г., 23:26 ч. UTC

Novavax Inc. shares are trading roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of the one-month range.

13.08.2026 г., 19:16 ч. UTC

Novavax Inc. shares are higher today, maintaining strength above the 20-day moving average despite rising initial jobless claims reported by the Labor Department.

12.08.2026 г., 23:31 ч. UTC

Novavax Inc. shares are lower in after-market trading, reflecting a weaker trend despite earlier gains. The stock remains above its 20-day moving average.

11.08.2026 г., 23:51 ч. UTC

Novavax Inc. shares are higher in after-market trading, maintaining a position above the 20-day moving average within its one-month trading range.

10.08.2026 г., 23:46 ч. UTC

Novavax Inc. shares are lower in after-market trading, showing some volatility since Monday's close and remaining within the middle of their one-month trading range.

7.08.2026 г., 19:36 ч. UTC

News

Novavax Inc shares are higher today, supported by $57 million in second-quarter revenue and ongoing discussions with Sanofi on a COVID-19/influenza vaccine.

6.08.2026 г., 23:01 ч. UTC

News

Novavax Inc expects 2026 revenue of $235 million to $275 million. Shares are trading higher in after-market hours following the earnings call.

5.08.2026 г., 23:01 ч. UTC

Novavax shares are higher in after-market trading, though they remain below the 20-day moving average amid weaker-than-expected U.S. job growth data.

4.08.2026 г., 23:36 ч. UTC

Novavax Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average. Broader market sentiment may support this upward movement.

3.08.2026 г., 23:46 ч. UTC

News

Novavax Inc is advancing in after-market trading as it shifts focus to licensing its Matrix-M adjuvant, attracting positive retail investor sentiment ahead of earnings.

31.07.2026 г., 19:16 ч. UTC

Novavax Inc. shares are lower today, reflecting a decline from Thursday's close amid rising bond yields and crude oil prices contributing to inflation concerns.

30.07.2026 г., 22:01 ч. UTC

Novavax Inc. shares advanced in after-market trading, rebounding from earlier session lows, though they remain below the 20-day moving average.

29.07.2026 г., 23:06 ч. UTC

Novavax Inc. shares are higher in after-market trading, gaining slightly since Wednesday's close, despite broader market weakness and significant declines over the past month.

28.07.2026 г., 16:06 ч. UTC

Novavax Inc. shares are lower today, reflecting broader market declines amid investor caution ahead of earnings and the Federal Reserve's interest rate decision.

27.07.2026 г., 14:02 ч. UTC

Novavax Inc shares are higher in pre-market trading, rising to $7.73. This increase occurs amid three consecutive lower session closes and mixed economic data.

24.07.2026 г., 18:46 ч. UTC

Novavax Inc. shares are lower today, continuing a trend of declines following three consecutive sessions of lower closes and trading below the 20-day moving average.

23.07.2026 г., 09:01 ч. UTC

Novavax Inc shares are higher in pre-market trading, reflecting upward momentum since Wednesday. Broader market sentiment remains positive amid rising Asian equity indices.

22.07.2026 г., 23:11 ч. UTC

Novavax Inc. shares are higher in after-market hours, driven by strength in biotechnology stocks. The company remains below its 20-day moving average.

21.07.2026 г., 22:46 ч. UTC

Novavax Inc. shares declined in after-market trading, remaining below their 20-day moving average despite a broader market rebound in the tech sector.

20.07.2026 г., 23:46 ч. UTC

Novavax Inc. shares traded roughly flat after-market with no specific news identified. The stock remains significantly below its 20-day moving average.

Сравнение с други в отрасъла

Ценова промяна

Novavax Inc Прогноза

Ценова цел

By TipRanks

48.21% нагоре

12-месечна прогноза

Среден 13.25 USD  48.21%

Висок 19 USD

Нисък 7 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Novavax Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

4 ratings

2

Купи

1

Задържане

1

Продай

Настроение

By Acuity

17 / 340 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
help-icon Live chat